Medtronic buys MacroPore product line for $21 million:
This article was originally published in Clinica
Executive Summary
Medtronic is to purchase San Diego, California-based MacroPore Biosurgery's Craniomaxillofacial/neurosurgical fixation product line for $21m in cash. Medtronic (Minneapolis, Minnesota) has been distributing the products for almost three years. The companies have also extended an existing co-development and supply agreement for spinal implants from 2005 to 2012. Neuer Markt-listed MacroPore will pay $4m to Medtronic for a waiver on the first rights to distribute MacroPore TS resorbable film product line in certain markets. MacroPore says the deals enable it to lower its operating costs, focus increasingly on biologics and invest in new market opportunities.